You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High-Risk MDS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, Adult Recurrent, MDS Trial in Durham (DVX201)

Recruiting
  • AML, Adult Recurrent
  • MDS
  • DVX201
  • Durham, North Carolina
    Duke University Hospital
Feb 11, 2022

Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +5 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 11, 2022

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Brasschaat, Belgium
  • +9 more
Jan 19, 2023

MDS, Acute Myeloid Leukemia Trial in New Haven (AG-120, Nivolumab)

Withdrawn
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • New Haven, Connecticut
    Yale Cancer Center
Jan 6, 2022

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

MDS, Chronic Myelomonocytic Leukemia (CMML) Trial (SNS-301)

Withdrawn
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia (CMML)
  • (no location specified)
Aug 9, 2021

MDS, AML Trial in France (ASTX727, Donor Lymphocyte Infusions)

Recruiting
  • MDS
  • AML
  • Amiens, France
  • +15 more
Jul 21, 2022

Acute Myeloid Leukemia, Adult, MDS Trial in Marseille, Paris, Pierre-Bénite (ABD-3001)

Active, not recruiting
  • Acute Myeloid Leukemia, Adult
  • Myelodysplastic Syndromes
  • Marseille, France
  • +2 more
Jan 19, 2023

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Chicago (Haplo-Cord Transplant, Matched Unrelated Donor

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Haplo-Cord Transplant
  • Matched Unrelated Donor Transplant
  • Chicago, Illinois
    University of Chicago Cancer Center
Feb 22, 2021

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

Leukemia, Myeloid, Acute, MDS, Myelodysplastic Syndrome Acute Myeloid Leukemia Trial in Denver (Nivolumab)

Withdrawn
  • Leukemia, Myeloid, Acute
  • +2 more
  • Denver, Colorado
    Colorado Blood Cancer Institute
Apr 20, 2021

Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • Durham, North Carolina
  • +8 more
Dec 13, 2022

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 23, 2022

Myelodysplastic Syndrome Trial in France (Azacitidine)

Completed
  • Myelodysplastic Syndrome
  • Amiens, France
  • +20 more
Dec 24, 2021

Leukemia, Acute, AML, Adult, ALL, Adult Trial in Charlottesville (Palliative Care Visits)

Recruiting
  • Leukemia, Acute
  • +3 more
  • Palliative Care Visits
  • Charlottesville, Virginia
    University of Virginia
Apr 28, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • +3 more
  • Venetoclax plus RIC
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Oct 12, 2022

MDS Trial in Bronx (Pyrimethamine)

Withdrawn
  • Myelodysplastic Syndromes
  • Bronx, New York
    Montefiore Medical Center
Sep 15, 2021

MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Adelaide, Australia
  • +11 more
Oct 13, 2022

Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Myelofibroses
  • Chicago, Illinois
    The University of Chicago
May 16, 2022

AML, Adult Recurrent, MDS Trial in United States (LYT-200)

Recruiting
  • AML, Adult Recurrent
  • MDS
  • Los Angeles, California
  • +13 more
Apr 12, 2023

Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Beijing, Beijing, China
  • +13 more
Aug 16, 2022

MDS, Progressive Disease Trial in Buffalo, Winston-Salem (CPI-613, Hydroxychloroquine)

Withdrawn
  • Myelodysplastic Syndromes
  • Progressive Disease
  • Buffalo, New York
  • +1 more
Apr 8, 2021